{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T06:51:31Z","timestamp":1771829491410,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010200","name":"U.S. Army Medical Research Institute of Chemical Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006225","name":"Oak Ridge Associated Universities","doi-asserted-by":"publisher","award":["DE-SC0014664"],"award-info":[{"award-number":["DE-SC0014664"]}],"id":[{"id":"10.13039\/100006225","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.taap.2024.116970","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T11:15:14Z","timestamp":1716203714000},"page":"116970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Seizure suppression and neuroprotection in soman-exposed rats following delayed intramuscular treatment of adenosine A1 receptor agonist as an adjunct to standard medical treatment"],"prefix":"10.1016","volume":"488","author":[{"given":"Zora-Maya","family":"Keith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crystal","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"Acon-Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Ming","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.taap.2024.116970_bb0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/(SICI)1099-1263(199811\/12)18:6<393::AID-JAT528>3.0.CO;2-0","article-title":"Review of health consequences from high-, intermediate- and low-level exposure to organophosphorus nerve agents","volume":"18","author":"Brown","year":"1998","journal-title":"Appl. Toxicol."},{"issue":"11","key":"10.1016\/j.taap.2024.116970_bb0010","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s00204-002-0395-x","article-title":"Therapeutic efficacy of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) against organophosphate intoxication","volume":"76","author":"Bueters","year":"2002","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.taap.2024.116970_bb0015","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1124\/jpet.102.044644","article-title":"Adenosine A1 receptor agonist N6-cyclopentyladenosine affects the inactivation of acetylcholinesterase in blood and brain by sarin","volume":"304","author":"Bueters","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.taap.2024.116970_bb0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.siny.2010.02.002","article-title":"Synergistic neuroprotective therapies with hypothermia","volume":"15","author":"Cilio","year":"2010","journal-title":"Semin. Fetal Neonatal Med."},{"issue":"1","key":"10.1016\/j.taap.2024.116970_bb0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.neuro.24.1.31","article-title":"The role and regulation of adenosine in the central nervous system","volume":"24","author":"Dunwiddie","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.taap.2024.116970_bb0030","series-title":"Society of Toxicology 62nd Annual Meeting & ToxExpo, Nashville, TN","article-title":"Learning and memory function preserved by delayed adenosine a1 agonist treatment following organophosphorus agent intoxication in rodents as displayed by improved performance of an active avoidance shuttle box assay","author":"Harkins","year":"2023"},{"issue":"1","key":"10.1016\/j.taap.2024.116970_bb0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00204-003-0513-4","article-title":"Cardiovascular effects of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) decisive for its therapeutic efficacy in sarin poisoning","volume":"78","author":"Joosen","year":"2004","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.taap.2024.116970_bb0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1941874413519802","article-title":"Therapeutic hypothermia for neuroprotection: history, mechanisms, risks, and clinical applications","volume":"4","author":"Karnatovskaia","year":"2014","journal-title":"Neurohospitalist"},{"issue":"3","key":"10.1016\/j.taap.2024.116970_bb0045","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1152\/jn.91062.2008","article-title":"A simple quantitative method for analyzing electrographic status epilepticus in rats","volume":"101","author":"Lehmkuhle","year":"2009","journal-title":"J. Neurophysiol."},{"issue":"2021","key":"10.1016\/j.taap.2024.116970_bb0050","article-title":"Intramuscularly administered A1 adenosine receptor agonists as delayed treatment for organophosphorus nerve agent-induced status epilepticus","volume":"419","author":"Loughery","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2024.116970_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2018.01.010","article-title":"Dexmedetomidine stops benzodiazepine-refractory nerve agent-induced status epilepticus","volume":"141","author":"McCarren","year":"2018","journal-title":"Epilepsy Res."},{"issue":"5","key":"10.1016\/j.taap.2024.116970_bb0060","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0149-7634(96)00050-4","article-title":"Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology","volume":"21","author":"McDonough","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.taap.2024.116970_bb0065","first-page":"123","article-title":"Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment","volume":"16","author":"McDonough","year":"1995","journal-title":"Neurotoxicology"},{"issue":"3","key":"10.1016\/j.taap.2024.116970_bb0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/01480540903483417","article-title":"Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in guinea pigs","volume":"33","author":"McDonough","year":"2010","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.taap.2024.116970_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2021.115466","article-title":"Evaluation of adenosine A1 receptor agonists as neuroprotective countermeasures against soman intoxication in rats","volume":"416","author":"Meads","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2024.116970_bb0080","series-title":"Goodman & Gilman\u2019s the Pharmacological Basis of Therapeutics","first-page":"457","article-title":"Chapter 17: Hypnotics and sedatives","author":"Mihic","year":"2011"},{"key":"10.1016\/j.taap.2024.116970_bb0085","series-title":"Annual Society for Neuroscience Meeting. Chicago, IL. Abstract #1777","article-title":"Hypothermia to recover neuropathology and survival after soman-induced seizure","author":"Munoz","year":"2021"},{"key":"10.1016\/j.taap.2024.116970_bb0090","doi-asserted-by":"crossref","first-page":"109966","DOI":"10.1016\/j.neuropharm.2024.109966","article-title":"Hypothermia as potential therapeutic approach to attenuating Soman-induced seizure, neuropathology, and mortality with an adenosine A1 receptor agonist and body cooling","author":"Munoz","year":"2024","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.taap.2024.116970_bb0095","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/acn3.262","article-title":"Neuroprotective effects of deep hypothermia in refractory status epilepticus","volume":"2","author":"Niquet","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"2","key":"10.1016\/j.taap.2024.116970_bb0100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1901\/jeab.1994.61-319","article-title":"Neurology and neuropathology of Soman-induced brain injury: an overview","volume":"61","author":"Petras","year":"1994","journal-title":"J. Exp. Anal. Behav."},{"issue":"1","key":"10.1016\/j.taap.2024.116970_bb0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.toxlet.2011.04.008","article-title":"The therapeutic use of localized cooling in the treatment of VX poisoning","volume":"204","author":"Sawyer","year":"2011","journal-title":"Toxicol. Lett."},{"issue":"5","key":"10.1016\/j.taap.2024.116970_bb0110","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjp.0706043","article-title":"Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists","volume":"144","author":"Schindler","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.taap.2024.116970_bb0115","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0361-9230(91)90097-4","article-title":"Cholinergic actions of diazepam and atropine sulfate in soman poisoning","volume":"26","author":"Shih","year":"1991","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.taap.2024.116970_bb0120","doi-asserted-by":"crossref","first-page":"116437","DOI":"10.1016\/j.taap.2023.116437","article-title":"A novel genetically modified mouse seizure model for evaluating anticonvulsive and neuroprotective efficacy of an A1 adenosine receptor agonist following soman intoxication","volume":"464","author":"Shih","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.taap.2024.116970_bb0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0149-7634(05)80028-4","article-title":"Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms","volume":"15","author":"Shih","year":"1991","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.taap.2024.116970_bb0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0041-008X(03)00019-X","article-title":"Control of nerve agent-induced seizures is critical for neuroprotection and survival","volume":"188","author":"Shih","year":"2003","journal-title":"Toxicol. App. Pharamcol."},{"issue":"1","key":"10.1016\/j.taap.2024.116970_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jcp.21579","article-title":"Mechanisms of induction of adenosine receptor genes and its functional significance","volume":"218","author":"St. Hilaire","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.taap.2024.116970_bb0140","series-title":"Goodman & Gilman\u2019s the Pharmacological Basis of Therapeutics","first-page":"239","article-title":"Chapter 10: Anticholinesterase agents","author":"Taylor","year":"2011"},{"issue":"6","key":"10.1016\/j.taap.2024.116970_bb0145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/15376516.2014.920450","article-title":"Stimulation of central A1 adenosine receptors suppresses seizure and neuropathology in a soman nerve agent seizure rat model","volume":"24","author":"Thomas","year":"2014","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.taap.2024.116970_bb0150","series-title":"US Army Medical Research Institute of Chemical Defense Tech Report, USAMRICD-TR-15-03 (DTIC #ADA621400)","article-title":"Evaluating the anti-seizure efficacy of novel adenosine treatment regimens in a soman rat model","author":"Thomas","year":"2015"},{"issue":"5","key":"10.1016\/j.taap.2024.116970_bb0155","first-page":"1","article-title":"The use of adenosine agonists to treat nerve agent-induced seizure and neuropathology","volume":"17","author":"Thomas","year":"2019","journal-title":"Biomed. J. Sci. Tech. Res."},{"key":"10.1016\/j.taap.2024.116970_bb0160","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12640-019-00034-w","article-title":"In vivo evaluation of A1 adenosine agonists as novel anticonvulsant medical countermeasures to nerve agent intoxication in a rat soman seizure model","volume":"36","author":"Thomas","year":"2019","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.taap.2024.116970_bb0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/01480549809007409","article-title":"New generic approach to the treatment of organophosphate poisoning: adenosine receptor mediated inhibition of ACh-release","volume":"21","author":"Van Helden","year":"1998","journal-title":"Drug Chem. Toxicol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24001686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24001686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:48:48Z","timestamp":1762220928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X24001686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":33,"alternative-id":["S0041008X24001686"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.116970","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seizure suppression and neuroprotection in soman-exposed rats following delayed intramuscular treatment of adenosine A1 receptor agonist as an adjunct to standard medical treatment","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.116970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116970"}}